Artal Group S.A. Oric Pharmaceuticals, Inc. Transaction History

Artal Group S.A.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	BUY	$17.37 - $25.34 $5.21 Million - $7.6 Million	300,000 Added 300.0%	400,000 $7.08 Million
Q4 2020 Feb 11, 2021	SELL	$20.32 - $39.8 $863,600 - $1.69 Million	-42,500 Reduced 29.82%	100,000 $3.39 Million
Q3 2020 Nov 13, 2020	SELL	$19.5 - $31.26 $146,250 - $234,450	-7,500 Reduced 5.0%	142,500 $3.56 Million
Q2 2020 Aug 14, 2020	BUY	$25.68 - $38.12 $3.85 Million - $5.72 Million	150,000 New	150,000 $5.06 Million

124

66.6M

7.8K

700

Ticker ORIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,576,700
Market Cap $336M
Description
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

Stay updated on Artal Group S.A. with notifications on news.